Artificial intelligence could spot hidden cancer spread before It's too late

NCT ID NCT07616011

Not yet recruiting Knowledge-focused Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test an artificial intelligence system designed to give early warning of cancer spreading to other parts of the body. Current imaging can only see larger tumors, but this AI analyzes routine scans and patient data to detect signs of microscopic spread. Researchers will follow 10,000 cancer patients over time to see if the AI can predict metastasis earlier than standard methods, potentially giving doctors a head start on treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Artificial intelligence-based early warning system
What this could lead to: If successful, this could provide a non-invasive, cost-effective way to detect cancer spread earlier, potentially improving survival and reducing metastasis rates.
What could go wrong: This is an early-stage observational study, not a treatment trial. The AI model may not perform as well in real-world settings as in retrospective data, and results may not apply to all cancer types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer metastatic malignant neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MALIGNANT TUMOR WITH METASTASIS

More trials for these conditions

Other studies related to the condition(s) this trial covers.